Clinical Trial: A Phase Ia/Ib Study of HW221043 in Participants With Advanced Solid Tumors

U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07719920) titled 'A Phase Ia/Ib Study of HW221043 in Participants With Advanced Solid Tumors' on July 17.

Brief Summary: This is a Phase Ia/Ib, dose escalation and dose expansion study to evaluate the safety, tolerability, PK, and preliminary efficacy of HW221043 tablets in participants with advanced solid tumors. It includes two parts: the dose escalation study (Phase Ia) and the dose expansion study (Phase Ib).

Study Start Date: July 30

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumors

Intervention: DRUG: HW221043 Tablets

HW221043 Tablets for oral administration at specified doses on scheduled days.

Recruitment Status: NOT_YET_REC...